Ameritas Investment Partners, Inc. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$133,331
+27.6%
18,832
+26.9%
0.01%
+25.0%
Q2 2023$104,488
-15.6%
14,8420.0%0.00%
-20.0%
Q1 2023$123,782
-21.5%
14,8420.0%0.01%
-16.7%
Q4 2022$157,770
-9.8%
14,842
+6.5%
0.01%
-25.0%
Q3 2022$175,000
+19.0%
13,9400.0%0.01%
+33.3%
Q2 2022$147,000
-35.2%
13,9400.0%0.01%
-25.0%
Q1 2022$227,000
+17.6%
13,9400.0%0.01%
+14.3%
Q4 2021$193,000
-3.5%
13,9400.0%0.01%0.0%
Q3 2021$200,000
-9.1%
13,9400.0%0.01%
-12.5%
Q2 2021$220,000
+43.8%
13,940
-7.4%
0.01%
+33.3%
Q1 2021$153,000
+36.6%
15,0520.0%0.01%
+20.0%
Q4 2020$112,000
+115.4%
15,0520.0%0.01%
+150.0%
Q3 2020$52,000
-14.8%
15,052
+18.2%
0.00%
-33.3%
Q2 2020$61,000
+144.0%
12,7300.0%0.00%
+200.0%
Q1 2020$25,000
-43.2%
12,7300.0%0.00%
-50.0%
Q4 2019$44,000
+83.3%
12,730
+53.4%
0.00%
+100.0%
Q3 2019$24,000
-22.6%
8,2970.0%0.00%0.0%
Q2 2019$31,000
-54.4%
8,2970.0%0.00%
-66.7%
Q1 2019$68,000
+1.5%
8,2970.0%0.00%
-25.0%
Q4 2018$67,000
+6.3%
8,2970.0%0.00%
+33.3%
Q3 2018$63,000
+31.2%
8,2970.0%0.00%
+50.0%
Q2 2018$48,000
+20.0%
8,2970.0%0.00%0.0%
Q1 2018$40,000
+21.2%
8,297
+23.9%
0.00%0.0%
Q4 2017$33,000
-2.9%
6,6970.0%0.00%0.0%
Q3 2017$34,000
-8.1%
6,6970.0%0.00%0.0%
Q2 2017$37,000
-21.3%
6,697
+19.7%
0.00%0.0%
Q1 2017$47,0005,5970.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders